Renal cancer survival in clear cell renal cancer compared to other types of tumor histology: A population-based cohort study
Abstract
Introduction Renal cancer (RC) presents a challenge with increasing incidence and mortality. This study compares RC cancer-specific survival (CSS) and overall survival (OS) based on histological type. Study design This population-based retrospective cohort study covers 1995–2017, utilizing cases from the Finnish Cancer Registry. Comorbidity, procedure and treatment information from 1995–2018 were obtained from the national health care registry, while death data originated from the national death certificate registry. RC cases were categorized by histology to analyze CSS and OS via Fine and Gray’s proportional sub-hazards model and Cox regression (adjusting for age, tumor extent, Charlson comorbidity index and treatment). Results The final cohort included 14,413 patients, predominantly ccRCC (75.5%), followed by papillary RCC (pRCC),5.8% and chromophobe RCC (chRCC) 2.1%. Univariate analysis showed better OS for non-ccRCC patients, with 5-year survival (5ySR) of 72.6% (95% CI 70.3–74.7%), compared to ccRCC (62.7%, 95%CI 61.8–63.5). Among non-ccRCC, the 5ySRs were as follows: pRCC 74.3% (95%CI 71.2–77.2), chRCC 82.2% (95% CI 77.2–86.1), sarcomatoid variants (sarcRC) 29.2% (95% CI 20.6–38.3), and collecting duct carcinoma (CDC) 23.5% (95%CI 7.3–44.9). Non-ccRCC showed improved CSS compared to ccRCC (sHR 0.69, 95% CI 0.60–0.78). Favorable CSS for chRCC (sHR 0.28, 95% CI 0.18–0.43) and pRCC (sHR 0.66, 95% CI 0.56–0.78), while sarcRC (sHR 1.83, 95% CI 1.36–2.46) and CDC (sHR 3.19,…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 14,413 participants or records.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.